CR20230129A - Proceso e intermediarios para preparar un inhibidor de jak - Google Patents
Proceso e intermediarios para preparar un inhibidor de jakInfo
- Publication number
- CR20230129A CR20230129A CR20230129A CR20230129A CR20230129A CR 20230129 A CR20230129 A CR 20230129A CR 20230129 A CR20230129 A CR 20230129A CR 20230129 A CR20230129 A CR 20230129A CR 20230129 A CR20230129 A CR 20230129A
- Authority
- CR
- Costa Rica
- Prior art keywords
- preparing
- intermediates
- jak inhibitor
- jak
- inhibitor
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 229940122245 Janus kinase inhibitor Drugs 0.000 title 1
- 239000002144 L01XE18 - Ruxolitinib Substances 0.000 abstract 1
- HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical compound C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 abstract 1
- 229960000215 ruxolitinib Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
La presente invención se relaciona con procesos para preparar ruxolitinib, o una sal de este, e intermediarios relacionados sintéticos asociados a estos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063067097P | 2020-08-18 | 2020-08-18 | |
US202163214012P | 2021-06-23 | 2021-06-23 | |
US202163217498P | 2021-07-01 | 2021-07-01 | |
PCT/US2021/046298 WO2022040180A1 (en) | 2020-08-18 | 2021-08-17 | Process and intermediates for preparing a jak inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20230129A true CR20230129A (es) | 2023-07-13 |
Family
ID=77655708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20230129A CR20230129A (es) | 2020-08-18 | 2021-08-17 | Proceso e intermediarios para preparar un inhibidor de jak |
Country Status (16)
Country | Link |
---|---|
US (1) | US11905292B2 (es) |
EP (1) | EP4200300A1 (es) |
JP (1) | JP2023539126A (es) |
KR (1) | KR20230096973A (es) |
AU (1) | AU2021329303A1 (es) |
CA (1) | CA3192099A1 (es) |
CL (1) | CL2023000480A1 (es) |
CO (1) | CO2023003281A2 (es) |
CR (1) | CR20230129A (es) |
DO (1) | DOP2023000035A (es) |
EC (1) | ECSP23019417A (es) |
IL (1) | IL300555A (es) |
MX (1) | MX2023002037A (es) |
PE (1) | PE20231743A1 (es) |
TW (1) | TW202227448A (es) |
WO (1) | WO2022040180A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117043152A (zh) | 2020-08-18 | 2023-11-10 | 因赛特公司 | 用于制备jak1抑制剂的方法和中间体 |
CN115850115B (zh) * | 2022-11-25 | 2023-08-01 | 上海药坦药物研究开发有限公司 | 鲁索利替尼中间体及其制备方法 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB812366A (en) | 1955-08-18 | 1959-04-22 | Wellcome Found | Improvements in and relating to derivatives of pyrimidine and the preparation thereof |
US5102904A (en) | 1989-12-08 | 1992-04-07 | American Cyanamid Company | N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas |
WO2004021979A2 (en) | 2002-09-06 | 2004-03-18 | Smithkline Beecham Corporation | PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
WO2005116035A1 (en) | 2004-05-27 | 2005-12-08 | Pfizer Products Inc. | Pyrrolopyrimidine derivatives useful in cancer treatment |
AR054416A1 (es) | 2004-12-22 | 2007-06-27 | Incyte Corp | Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas. |
AU2006273762A1 (en) | 2005-07-29 | 2007-02-01 | Pfizer Products Inc. | Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
CN103214484B (zh) | 2005-12-13 | 2016-07-06 | 因塞特控股公司 | 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶 |
CN2928286Y (zh) | 2006-01-06 | 2007-08-01 | 水城钢铁(集团)有限责任公司 | 预入口导卫装置 |
NZ570084A (en) | 2006-02-02 | 2011-07-29 | Millennium Pharm Inc | Inhibitors of E1 activating enzymes |
CL2008001709A1 (es) | 2007-06-13 | 2008-11-03 | Incyte Corp | Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras. |
EP2740731B1 (en) | 2007-06-13 | 2016-03-23 | Incyte Holdings Corporation | Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
CN101815712A (zh) | 2007-08-01 | 2010-08-25 | 辉瑞有限公司 | 吡唑化合物及其作为raf抑制剂的用途 |
EA020777B1 (ru) | 2007-11-16 | 2015-01-30 | Инсайт Корпорейшн | 4-пиразолил-n-арилпиримидин-2-амины, 4-пиразолил-n-пиразолилпиримидин-2-амины и 4-пиразолил-n-пиридилпиримидин-2-амины в качестве ингибиторов киназ janus |
SI2288610T1 (sl) | 2008-03-11 | 2016-11-30 | Incyte Holdings Corporation | Derivati azetidina in ciklobutana kot inhibitorji jak |
CL2009001884A1 (es) | 2008-10-02 | 2010-05-14 | Incyte Holdings Corp | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. |
JOP20190231A1 (ar) | 2009-01-15 | 2017-06-16 | Incyte Corp | طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به |
CA2756250A1 (en) | 2009-04-10 | 2010-10-14 | Pfizer Inc. | 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
US8716303B2 (en) | 2009-05-22 | 2014-05-06 | Incyte Corporation | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
HUE046493T2 (hu) | 2009-05-22 | 2020-03-30 | Incyte Holdings Corp | 3-[4-(7H-Pirrolo[2,3-d]pirimidin-4-il)-lH-pirazol-l-il]oktán- vagy heptán-nitril JAK inhibitorokként |
TW201113285A (en) | 2009-09-01 | 2011-04-16 | Incyte Corp | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
PL2486041T3 (pl) | 2009-10-09 | 2014-01-31 | Incyte Holdings Corp | Pochodne hydroksylowe, keto i glukuronidowe 3-(4-(7H-pirolo[2,3-d]pirymidyn-4-ylo)-1H-pirazol-1-ilo)-3-cyklopentylopropanonitrylu |
ES2633317T3 (es) | 2009-11-06 | 2017-09-20 | Plexxikon, Inc. | Compuestos y métodos para la modulación de quinasas, e indicaciones para ello |
BR112012011792A2 (pt) | 2009-11-18 | 2015-10-13 | Plexxikon Inc | "compostos e métodos para modulação de quinases, e indicações para os mesmos" |
EA023444B1 (ru) | 2010-02-18 | 2016-06-30 | Инсайт Холдингс Корпорейшн | Циклобутановые и метилциклобутановые производные, композиции на их основе и способы их применения |
MY175156A (en) | 2010-03-10 | 2020-06-11 | Incyte Corp | Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
TWI619713B (zh) | 2010-04-21 | 2018-04-01 | 普雷辛肯公司 | 用於激酶調節的化合物和方法及其適應症 |
TWI499421B (zh) | 2010-05-21 | 2015-09-11 | Incyte Corp | Jak抑制劑的局部製劑 |
CN103415515B (zh) | 2010-11-19 | 2015-08-26 | 因塞特公司 | 作为jak抑制剂的环丁基取代的吡咯并吡啶和吡咯并嘧啶衍生物 |
JP5917544B2 (ja) | 2010-11-19 | 2016-05-18 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン |
AU2012273164B2 (en) | 2011-06-20 | 2015-05-28 | Incyte Holdings Corporation | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors |
IN2014MN00228A (es) | 2011-08-12 | 2015-09-25 | Nissan Chemical Ind Ltd | |
TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為jak抑制劑之環己基氮雜環丁烷衍生物 |
UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
US9193733B2 (en) | 2012-05-18 | 2015-11-24 | Incyte Holdings Corporation | Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors |
WO2014078486A1 (en) | 2012-11-15 | 2014-05-22 | Incyte Corporation | Sustained-release dosage forms of ruxolitinib |
ES2707355T3 (es) | 2013-03-06 | 2019-04-03 | Incyte Holdings Corp | Procesos y productos intermedios para elaborar un inhibidor de JAK |
ME02763B (me) | 2013-05-17 | 2018-01-20 | Incyte Corp | Derivati bipirazola kao inhibitori jak |
CA3155500A1 (en) | 2013-08-07 | 2015-02-12 | Incyte Corporation | Sustained release dosage forms for a jak1 inhibitor |
CA2947418A1 (en) | 2014-04-30 | 2015-11-05 | Incyte Corporation | Processes of preparing a jak1 inhibitor and new forms thereto |
EP3183253B1 (en) * | 2014-08-21 | 2018-06-27 | ratiopharm GmbH | Salt of (r)-3-(4-(7h-pyrrolo [2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3-cyclopentylpropanenitrile with benzenesulfonic acid |
ES2874537T3 (es) | 2014-08-21 | 2021-11-05 | Ratiopharm Gmbh | Sal oxalato de ruxolitinib |
WO2016035014A1 (en) | 2014-09-01 | 2016-03-10 | Sun Pharmaceutical Industries Limited | Processes for the preparation of ruxolitinib phosphate |
WO2016063294A2 (en) | 2014-10-20 | 2016-04-28 | Msn Laboratories Private Limited | Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof |
CN107278205A (zh) | 2015-02-24 | 2017-10-20 | 辉瑞大药厂 | 用作抗癌药的取代的核苷衍生物 |
CN106397443A (zh) | 2015-07-17 | 2017-02-15 | 浙江九洲药业股份有限公司 | 一种吡咯嘧啶类衍生物中间体的制备方法 |
CZ2015575A3 (cs) | 2015-08-26 | 2017-03-08 | Zentiva, K.S. | Soli 5-fluoro-3-fenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-onu a jejich příprava |
AU2016379454B2 (en) | 2015-12-23 | 2021-01-28 | The University Of British Columbia | Lipid-linked prodrugs |
JP6921087B2 (ja) | 2015-12-31 | 2021-08-18 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. | ルキソリチニブの合成プロセス |
CZ201629A3 (cs) | 2016-01-22 | 2017-08-02 | Zentiva, K.S. | Krystalické modifikace solí (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu a způsoby jejich přípravy |
CN107513069A (zh) | 2016-06-16 | 2017-12-26 | 正大天晴药业集团股份有限公司 | 手性吡咯并嘧啶化合物的制备方法 |
IN201641026603A (es) | 2016-08-04 | 2018-02-09 | ||
CN107722012B (zh) | 2016-08-11 | 2020-05-29 | 斯福瑞(南通)制药有限公司 | 制备4-氯-7H-吡咯并[2,3-d]嘧啶的方法 |
CN107759601B (zh) | 2016-08-23 | 2020-09-11 | 苏州旺山旺水生物医药有限公司 | 一种jak抑制剂及其盐的制备方法 |
CN107759623B (zh) | 2016-08-23 | 2020-08-14 | 苏州旺山旺水生物医药有限公司 | Jak抑制剂的中间体及其制备方法 |
EP3515909A1 (en) | 2016-09-23 | 2019-07-31 | Cellipse | Lim kinase inhibitors, pharmaceutical composition and method of use in limk-mediated diseases |
CN109651424B (zh) | 2017-10-11 | 2021-01-22 | 新发药业有限公司 | 一种7-保护基-4-(1-氢-吡唑-4-基)吡咯[2,3-d]嘧啶的合成方法 |
US10766900B2 (en) | 2017-12-29 | 2020-09-08 | Formosa Laboratories, Inc. | Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof |
MA51771B1 (fr) | 2018-01-30 | 2022-03-31 | Incyte Corp | Procédés de préparation de (1-(3-fluoro-2-(trifluorométhyl)isonicotinyl)pipéridine-4-one) |
EP3797099B1 (en) | 2018-05-21 | 2023-11-01 | PI Industries Ltd. | Method for preparing substituted heterocyclic compounds |
JP2022520047A (ja) | 2019-02-06 | 2022-03-28 | コンサート ファーマシューティカルズ インコーポレイテッド | 鏡像異性的に濃縮されたjak阻害剤を調製するための方法 |
CN110724145A (zh) | 2019-11-01 | 2020-01-24 | 廖文杰 | 一种医药中间体4-氯吡咯并嘧啶的合成方法 |
CN117043152A (zh) | 2020-08-18 | 2023-11-10 | 因赛特公司 | 用于制备jak1抑制剂的方法和中间体 |
CA3226714A1 (en) | 2021-07-12 | 2023-01-19 | Incyte Corporation | Process and intermediates for preparing baricitinib |
CN113480546A (zh) | 2021-07-30 | 2021-10-08 | 江苏君若药业有限公司 | 巴瑞克替尼及其衍生物的制备 |
-
2021
- 2021-08-17 CR CR20230129A patent/CR20230129A/es unknown
- 2021-08-17 US US17/404,613 patent/US11905292B2/en active Active
- 2021-08-17 CA CA3192099A patent/CA3192099A1/en active Pending
- 2021-08-17 WO PCT/US2021/046298 patent/WO2022040180A1/en active Application Filing
- 2021-08-17 MX MX2023002037A patent/MX2023002037A/es unknown
- 2021-08-17 AU AU2021329303A patent/AU2021329303A1/en active Pending
- 2021-08-17 IL IL300555A patent/IL300555A/en unknown
- 2021-08-17 KR KR1020237009291A patent/KR20230096973A/ko unknown
- 2021-08-17 PE PE2023000317A patent/PE20231743A1/es unknown
- 2021-08-17 EP EP21766351.7A patent/EP4200300A1/en active Pending
- 2021-08-17 JP JP2023512140A patent/JP2023539126A/ja active Pending
- 2021-08-18 TW TW110130538A patent/TW202227448A/zh unknown
-
2023
- 2023-02-16 CL CL2023000480A patent/CL2023000480A1/es unknown
- 2023-02-17 DO DO2023000035A patent/DOP2023000035A/es unknown
- 2023-03-16 EC ECSENADI202319417A patent/ECSP23019417A/es unknown
- 2023-03-16 CO CONC2023/0003281A patent/CO2023003281A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2021329303A1 (en) | 2023-04-06 |
CO2023003281A2 (es) | 2023-06-30 |
JP2023539126A (ja) | 2023-09-13 |
MX2023002037A (es) | 2023-06-12 |
US20220056035A1 (en) | 2022-02-24 |
CA3192099A1 (en) | 2022-02-24 |
PE20231743A1 (es) | 2023-10-31 |
IL300555A (en) | 2023-04-01 |
KR20230096973A (ko) | 2023-06-30 |
DOP2023000035A (es) | 2023-06-15 |
US11905292B2 (en) | 2024-02-20 |
TW202227448A (zh) | 2022-07-16 |
WO2022040180A1 (en) | 2022-02-24 |
ECSP23019417A (es) | 2023-04-28 |
CL2023000480A1 (es) | 2023-08-04 |
EP4200300A1 (en) | 2023-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20230130A (es) | Proceso e intermedios para preparar un inhibidor de jak1 | |
PH12019502264A1 (en) | Fused imidazo-piperidine jak inhibitors compound | |
CR20230129A (es) | Proceso e intermediarios para preparar un inhibidor de jak | |
PH12019502286A1 (en) | Process for preparing an optically active pyrimidinium compounds | |
PH12021550388A1 (en) | Process for preparing jak inhibitors and intermediates thereof | |
MX2021015546A (es) | Proceso para preparar 4-amino-piridazinas. | |
PH12019502386A1 (en) | Process for preparing s-containing pyrimidinium compounds | |
MX2021008965A (es) | Proceso para preparar un agonista dual de gip/glp1. | |
MX2019010642A (es) | Inhibidores de cinasa activada por mitogeno 2 (mk2), sintesis de los mismos, e intermediarios de los mismos. | |
EP4265597A3 (en) | Synthesis of omecamtiv mecarbil | |
MX2021003070A (es) | Un proceso de fabricación de compuestos heterocíclicos de 2-nitroimino. | |
EA202090933A1 (ru) | Способ получения гербицидных соединений пиридазинона | |
MX2022002017A (es) | Metodo para producir derivado de heterociclideno acetamida. | |
MX2019009242A (es) | Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-c iclopropanos. | |
MX2019001228A (es) | Metodo de produccion del compuesto de pirazol-amida. | |
WO2018007973A3 (en) | Process and intermediates for preparing benzoxazepines | |
MX2021007511A (es) | Procedimiento para la preparacion de anilinas sustituidas. | |
MX2023004950A (es) | Proceso para purificacion de pleuromutilinas. | |
MX2023000970A (es) | Metodo de preparacion de aminofuranos. | |
CL2021000663A1 (es) | Proceso para la producción de gas de síntesis. | |
MX2020010343A (es) | Proceso para la purificacion de biocomposiciones complejas. | |
IL279168B (en) | A process for the preparation of eribulin | |
MX2020006070A (es) | Proceso de producción de n-acetil taurinato de magnesio. | |
MX2022006044A (es) | Proceso para preparar analogos de araquidonoiletanolamina. | |
MX2022006856A (es) | Proceso e intermediarios para la produccion de formula (i). |